MacDonald Sean Arthur reported grant involving 19,000 shares of Edesa Biotech, Inc. at $0.00 for $0 on May 27, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed May 29, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
19,000Common Shares
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
41,054Direct
Trade date
May 27, 2026Grant
Filed
May 29, 2026, 5:02 PM ET2-day reporting delay
Accession
0001171843-26-003804Code A · Transaction 94171
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

EDSA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
EDSA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +55%1w ago +51%1d ago +34%
Returns since7d −24%30d +13%90d180d1y

Footnotes in full

F1: Reflects a grant of restricted share units issued pursuant to the Issuer's 2019 Equity Incentive Compensation Plan, which shall vest in equal proportions over twelve (12) months, commencing on the grant date.